V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011470 | 310004196 | 1.66 | 86 | Palliative (P) | 2017-07-19 | 2017-08-10 | Mini BEAM | 02 | null | 310014991 | BEAM |
| 310011471 | 310004211 | null | 95 | Palliative (P) | 2015-01-29 | 2015-02-12 | GEM-P | 02 | N | 310015060 | GEMCITABINE + PACLITAXEL |
| 310011472 | 310009647 | 1.91 | 49.95 | Palliative (P) | 2015-12-28 | 2016-06-15 | GEM-P | 02 | N | 310015428 | GEMCITABINE + PACLITAXEL |
| 310011473 | 310007781 | 1.72 | 71.2 | Palliative (P) | 2016-07-02 | 2016-07-08 | GEMCITABINE | 02 | null | 310015652 | GEMCITABINE |
| 310011474 | 310004271 | null | 101.9 | Disease modification (D) | null | 2017-03-09 | Brentuximab Vedotin | 2 | N | 310015687 | BRENTUXIMAB |
| 310011475 | 310004319 | 1.88 | null | Curative (C) | 2020-05-10 | 2020-05-10 | BEAM | 2 | N | 310016231 | BEAM |
| 310011476 | 310004333 | 1.79 | 108.7 | Curative (C) | 2015-02-09 | 2015-02-09 | Carboplatin + Liposomal Doxorubicin | N | N | 310016377 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011478 | 310004366 | 1.58 | 51.3 | Curative (C) | 2016-05-14 | 2016-05-20 | IVE | N | N | 310016833 | IVE |
| 310011480 | 310004416 | 1.68 | 65.4 | null | 2014-09-13 | 2015-02-01 | LEAM | null | null | 310017276 | LEAM |
| 310011481 | 310007869 | null | 68.9 | Curative (C) | 2016-08-05 | 2016-08-05 | IVE | 02 | null | 310017432 | IVE |
| 310011482 | 310004448 | 1.64 | 112 | Palliative (P) | 2017-04-24 | 2017-09-01 | GEM-P | N | N | 310017474 | GEMCITABINE + PACLITAXEL |
| 310011483 | 310007886 | null | 63.9 | Palliative (P) | 2019-07-17 | 2020-01-17 | Gemcitabine + Methylprednisolone | N | N | 310017644 | GEMCITABINE |
| 310011484 | 310004483 | null | 93.2 | Palliative (P) | 2017-11-26 | 2017-11-27 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310017721 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011486 | 310004517 | 1.53 | 74 | Palliative (P) | 2018-03-15 | 2018-03-22 | Carboplatin + Liposomal Doxorubicin | N | N | 310017909 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011487 | 310004538 | 1.8 | null | Disease modification (D) | 2018-11-12 | 2018-11-13 | BEAM | 02 | N | 310018037 | BEAM |
| 310011488 | 310004543 | 1.63 | 90.3 | Palliative (P) | 2019-05-17 | 2019-05-24 | PEMBROLIZUMAB | 01 | N | 310018046 | PEMBROLIZUMAB |
| 310011489 | 310004550 | 1.72 | 89.2 | Palliative (P) | 2017-11-04 | 2018-07-04 | Gemcitabine + Methylprednisolone | Y | N | 310018083 | GEMCITABINE |
| 310011490 | 310004565 | null | 70.1 | Curative (C) | 2017-11-26 | 2017-11-27 | BEAM | N | N | 310018127 | BEAM |
| 310011491 | 310004583 | 1.63 | 71.9 | Palliative (P) | 2019-07-01 | 2019-07-09 | GEM-P | null | null | 310018245 | GEMCITABINE + PACLITAXEL |
| 310011492 | 310007948 | 1.69 | 79.1 | Curative (C) | 2015-09-20 | 2015-09-20 | IVE | 02 | N | 310018278 | IVE |
| 310011493 | 310010702 | 1.68 | 92 | Palliative (P) | null | 2017-01-28 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310018292 | CISPLATIN + GEMCITABINE |
| 310011494 | 310011252 | 1.54 | 74.7 | Palliative (P) | 2018-06-28 | 2018-07-23 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310018383 | CISPLATIN + GEMCITABINE |
| 310011495 | 310004623 | 1.55 | 66.3 | Palliative (P) | 2018-07-23 | 2018-07-25 | GEM-P | N | N | 310018446 | GEMCITABINE + PACLITAXEL |
| 310011496 | 310004629 | 1.63 | 85 | Curative (C) | 2015-08-18 | 2015-08-18 | PEMBROLIZUMAB | N | N | 310018458 | PEMBROLIZUMAB |
| 310011497 | 310007970 | 1.55 | null | Curative (C) | 2012-11-12 | 2014-06-20 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | 310018465 | NOT MATCHED |
| 310011498 | 310004636 | 1.58 | 82.3 | Palliative (P) | 2013-11-09 | 2013-11-09 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 310018467 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310011499 | 310007976 | 1.63 | null | Palliative (P) | 2019-12-20 | 2019-12-28 | Ipilimumab | N | N | 310018478 | IPILIMUMAB |
| 310011500 | 310004646 | 1.76 | 91.7 | Curative (C) | 2015-11-23 | 2015-11-23 | CYCLOPHOSPHAMIDE | N | N | 310018484 | CYCLOPHOSPHAMIDE |
| 310011501 | 310004651 | 1.73 | 99 | Curative (C) | 2016-08-17 | 2016-08-18 | Methotrexate intrathecal | 2 | N | 310018504 | METHOTREXATE INTRATHECAL |
| 310011502 | 310004671 | 1.62 | 72.2 | Palliative (P) | 2019-11-20 | 2019-11-29 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310018537 | DOCETAXEL + GEMCITABINE |
| 310011503 | 310004708 | 1.62 | 74 | Palliative (P) | 2018-12-03 | 2019-12-09 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 310018650 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310011504 | 310004720 | 1.72 | 83.4 | Curative (C) | 2014-09-18 | 2014-09-26 | CYCLOPHOSPHAMIDE | 02 | N | 310018685 | CYCLOPHOSPHAMIDE |
| 310011505 | 310004725 | 1.73 | 72.1 | Disease modification (D) | null | 2014-08-03 | Docetaxel + Gemcitabine (prior RT) | N | N | 310018688 | DOCETAXEL + GEMCITABINE |
| 310011506 | 310004731 | 1.52 | 96 | null | 2015-03-31 | 2015-04-23 | ETOPOSIDE | 02 | null | 310018701 | ETOPOSIDE |
| 310011507 | 310004740 | 1.59 | null | Curative (C) | 2017-09-11 | 2017-04-18 | Ipilimumab | N | N | 310018723 | IPILIMUMAB |
| 310011508 | 310004749 | 1.72 | 95 | Palliative (P) | 2019-01-03 | 2019-01-09 | Ipilimumab | 02 | N | 310018744 | IPILIMUMAB |
| 310011509 | 310004776 | 1.62 | null | Disease modification (D) | 2018-09-19 | 2019-03-03 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 310018871 | DOCETAXEL + GEMCITABINE |
| 310011510 | 310004783 | 1.67 | 51 | Palliative (P) | 2018-10-27 | 2018-12-15 | Docetaxel 75mg/m2 (21 day) | N | null | 310018888 | DOCETAXEL |
| 310011511 | 310004786 | 1.56 | null | Curative (C) | 2016-10-29 | 2016-10-31 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018896 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310011512 | 310004795 | 1.88 | 91.7 | Curative (C) | 2015-12-18 | 2016-01-25 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310018919 | DOCETAXEL + GEMCITABINE |
| 310011513 | 310004801 | 1.75 | 55.6 | null | 2015-11-28 | 2015-11-28 | ETOPOSIDE | N | N | 310018942 | ETOPOSIDE |
| 310011514 | 310004810 | 1.85 | 31.65 | Adjuvant (A) | 2016-11-13 | 2016-11-28 | Rituximab | N | null | 310018968 | RITUXIMAB |
| 310011515 | 310009794 | 1.8 | 77 | Palliative (P) | 2015-03-03 | 2015-03-19 | Cisplatin 7 day | 02 | null | 310018998 | CISPLATIN |
| 310011516 | 310004833 | null | 53 | Not known (9) | 2018-02-17 | 2018-03-16 | CARBOPLATIN + ETOPOSIDE | null | null | 310019038 | BEXAROTENE |
| 310011517 | 310004848 | null | 0 | Palliative (P) | 2016-09-06 | 2017-02-16 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310019087 | CARBOPLATIN + ETOPOSIDE |
| 310011518 | 310004865 | 1.76 | 68.3 | Disease modification (D) | 2015-01-08 | 2015-05-04 | Cyclophosphamide High Dose | N | N | 310019139 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310011519 | 310011265 | 1.5 | 67 | Curative (C) | 2014-05-16 | 2014-08-15 | Cyclophosphamide oral | 02 | null | 310019167 | CYCLOPHOSPHAMIDE |
| 310011520 | 310004910 | 1.75 | 81.8 | Palliative (P) | 2016-09-14 | 2016-09-14 | GDP | N | N | 310019366 | GDP |
| 310011521 | 310004912 | 1.73 | 96 | Palliative (P) | 2013-10-20 | 2013-10-21 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310019371 | BEXAROTENE |
| 310011522 | 310008122 | 1.53 | 76 | Palliative (P) | 2017-09-19 | 2017-12-30 | Bexarotene | 2 | N | 310019376 | ESHAP |